At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. Through our focused portfolio, we’re reimagining drug development across five therapeutic areas.
Cardiovascular, Renal and Metabolism
Cardiovascular (CV), renal and metabolic diseases are a global health crisis. Billions of people are affected physically, emotionally and financially. These chronic, complex, debilitating and often hereditary diseases are frequently inter-related. Yet there continues to be healthcare system and treatment barriers, and a lack of transformative medicines.
Thanks to a combination of our legacy, global footprint and leading science, Novartis is uniquely positioned to help change this landscape. Our efforts include use of early interventions and development of pioneering treatments that address the spectrum of CRM diseases, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from CV disease.
Immunology and Dermatology
Novartis is a global leader in immunology and dermatology. We are transforming the lives of people living with immunologic diseases, focusing on specialty dermatology, rheumatology, autoinflammatory, transplant, and specialty liver diseases where there remain high unmet medical needs.
Novartis is reimagining the treatment and prevention of visual impairment and blindness. We aim to develop life-changing pharmaceuticals and transformative technologies for diseases and conditions from front to back of the eye.
Novartis has been tackling neurological conditions for more than 80 years. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do. Together, we can innovate to reimagine neuroscience and improve people’s lives
At Novartis, our focus is on improving the lives of the hundreds of millions of people living with respiratory diseases, including chronic obstructive pulmonary disease (COPD) and severe allergic asthma.